Staidson (Beijing) BioPharmaceuticals Co., Ltd. (SHE:300204)
China flag China · Delayed Price · Currency is CNY
26.08
-0.42 (-1.58%)
Feb 13, 2026, 3:12 PM CST

SHE:300204 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Dec '21 Dec '20
Cash & Equivalents
15853.9185.18264.9985.01140.57
Short-Term Investments
-----120.73
Trading Asset Securities
----381.46461.24
Cash & Short-Term Investments
15853.9185.18264.99466.47722.54
Cash Growth
269.75%-36.71%-67.86%-43.19%-35.44%-8.52%
Accounts Receivable
45.6739.0761.22188.18157.9128.22
Other Receivables
0.940.641.141.381.181.29
Receivables
46.6139.7262.35189.56159.07129.51
Inventory
30.122.1820.9318.8325.0138.09
Prepaid Expenses
-0.010.01---
Other Current Assets
70.761.870.4155.6937.913.17
Total Current Assets
305.41177.62238.89529.06688.44903.32
Property, Plant & Equipment
216.68235261.36290.58312.43295.17
Long-Term Investments
477.13514.07549.54522.25545.43444.03
Goodwill
19.7519.7519.7519.7522.1722.17
Other Intangible Assets
36.6134.6735.1380.4882.2282.97
Long-Term Deferred Tax Assets
50.0850.08164198.13155.8479.87
Long-Term Deferred Charges
143.9117.8462.5726.975.2920.51
Other Long-Term Assets
14.360.580.982.0915.158.17
Total Assets
1,2641,1501,3321,6691,8271,856
Accounts Payable
14.9633.4972.9135.8731.7119.63
Accrued Expenses
8.9567.7183.85158.73150.01127.99
Short-Term Debt
41.6742.4240.9523.09-48
Current Portion of Leases
0.060.06-2.692.25-
Current Income Taxes Payable
2.43--0.02--
Current Unearned Revenue
3.33.892.863.271.341.14
Other Current Liabilities
52.66.887.68.111.3311.43
Total Current Liabilities
123.98154.45208.17231.77196.64208.2
Long-Term Leases
-0.06-3.185.37-
Long-Term Unearned Revenue
27.4929.9129.2433.4721.3223.35
Long-Term Deferred Tax Liabilities
48.5148.4374.1447.0352.9133.83
Other Long-Term Liabilities
204.24----3.32
Total Liabilities
404.22232.85311.55315.45276.25268.7
Common Stock
477.77477.77477.77475.36476.03476.03
Additional Paid-In Capital
558.6570.95534.46519.36536.44531.08
Retained Earnings
-280.05-249.37-83.63314.62510.98648
Treasury Stock
-----43.68-82.72
Comprehensive Income & Other
114.28129.8892.0644.5370.9715.11
Total Common Equity
870.61929.231,0211,3541,5511,588
Minority Interest
-10.91-12.47----
Shareholders' Equity
859.7916.761,0211,3541,5511,588
Total Liabilities & Equity
1,2641,1501,3321,6691,8271,856
Total Debt
41.7342.5440.9528.967.6348
Net Cash (Debt)
116.2611.3744.23236.03458.84674.54
Net Cash Growth
172.83%-74.28%-81.26%-48.56%-31.98%-14.60%
Net Cash Per Share
0.230.020.090.490.971.42
Filing Date Shares Outstanding
477.77477.77477.77475.36472.66469.65
Total Common Shares Outstanding
477.77477.77477.77475.36472.66469.65
Working Capital
181.4323.1830.72297.28491.8695.12
Book Value Per Share
1.821.942.142.853.283.38
Tangible Book Value
814.24874.81965.781,2541,4461,482
Tangible Book Value Per Share
1.701.832.022.643.063.16
Buildings
-215.93214.75184.57183.64183.07
Machinery
-317.62318.38254.98246.28237.66
Construction In Progress
---87.8285.4852.92
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.